EMRG:PA:PA-SSgA SPDR MSCI Emerging Markets UCITS (EUR)

ETF | Others |

Last Closing

USD 60.891

Change

-0.32 (-0.52)%

Market Cap

USD 0.74B

Volume

312.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.52 (-1.17%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

N/A

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.06 (+0.02%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.05 (-0.14%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.09 (-0.43%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.95 (+0.22%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.11 (+0.03%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.02 (-0.03%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.08 (-1.20%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.39 (+0.47%)

USD 5.54B

ETFs Containing EMRG:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.12% 52% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.12% 52% F 51% F
Trailing 12 Months  
Capital Gain 8.39% 71% C- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.39% 69% C- 71% C-
Trailing 5 Years  
Capital Gain 50.31% 36% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.31% 34% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 4.69% 35% F 49% F
Dividend Return 4.69% 33% F 25% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.32% 42% F 36% F
Risk Adjusted Return 32.78% 26% F 29% F
Market Capitalization 0.74B 73% C 75% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.